汕头大学学报:自然科学版
汕頭大學學報:自然科學版
산두대학학보:자연과학판
Journal of Shantou University(Natural Science Edition)
2012年
4期
37-45
,共9页
刘柳%沈志忠%朴仲贤%陈春桂%李伟秋%陈耀文%林珏龙
劉柳%瀋誌忠%樸仲賢%陳春桂%李偉鞦%陳耀文%林玨龍
류류%침지충%박중현%진춘계%리위추%진요문%림각룡
肥大细胞%食管癌细胞%F-actin%细胞周期%As203%流式细胞仪
肥大細胞%食管癌細胞%F-actin%細胞週期%As203%流式細胞儀
비대세포%식관암세포%F-actin%세포주기%As203%류식세포의
mast cell%F-actin%esophageal carcinoma%cell cycle%As2O3%flow cytometry
目的:细胞骨架微丝是与肿瘤细胞生长密切相关的因素之一,本文以生物机体腹腔为免疫的微环境,研究化疗药物三氧化二砷(As2O3)对人食管癌细胞株微丝骨架的影响.方法:利用鬼笔环肽(Phalloidin)及碘化丙碇(Propidium Iodide,PI)标记,以流式细胞仪技术分析小鼠腹腔液中食管癌ECl09细胞周期的各期细胞内F—actin的变化.结果:诱导肥大细胞(mastcell,MC)迁移入腹腔的同时,迅速升高G0/G1期细胞及降低S期细胞内的Factin含量,DNA检测结果显示G0/G1期的肿瘤细胞数量迅速增加(P〈0.05),s期细胞含量降低;三氧化二砷作用后,食管癌细胞各期的F-actin含量均降低,尤其s期为甚.MC和As2O3共同作用后,食管癌细胞各期的Factin含量均也减少,但G0/G1期细胞数量却显著增加.结论:在小鼠腹腔微环境中,免疫功能改变(免疫细胞MC的聚集)引起G0/G1期细胞数量迅速升高、S期细胞的数量降低,可能促使ECl09细胞G。/G,期向s期跨越的延迟;在此环境中,As2O3也可能通过抑制S期ECl09细胞内F—actin的重组来延迟细胞从G。/G。期进入S期;诱导肥大细胞迁入腹腔的同时加入药物As20,,其作用主要表现为短期效应,促进了肿瘤细胞内F—aetin含量的降低,G0/G1期细胞数量较高,出现短暂的延迟Gn/G1期向S期跨越,增强了对肿瘤细胞生长的抑制作用.因此,以生物机体为研究环境,可能更真实地呈现化疗药物对肿瘤细胞的治疗效果.
目的:細胞骨架微絲是與腫瘤細胞生長密切相關的因素之一,本文以生物機體腹腔為免疫的微環境,研究化療藥物三氧化二砷(As2O3)對人食管癌細胞株微絲骨架的影響.方法:利用鬼筆環肽(Phalloidin)及碘化丙碇(Propidium Iodide,PI)標記,以流式細胞儀技術分析小鼠腹腔液中食管癌ECl09細胞週期的各期細胞內F—actin的變化.結果:誘導肥大細胞(mastcell,MC)遷移入腹腔的同時,迅速升高G0/G1期細胞及降低S期細胞內的Factin含量,DNA檢測結果顯示G0/G1期的腫瘤細胞數量迅速增加(P〈0.05),s期細胞含量降低;三氧化二砷作用後,食管癌細胞各期的F-actin含量均降低,尤其s期為甚.MC和As2O3共同作用後,食管癌細胞各期的Factin含量均也減少,但G0/G1期細胞數量卻顯著增加.結論:在小鼠腹腔微環境中,免疫功能改變(免疫細胞MC的聚集)引起G0/G1期細胞數量迅速升高、S期細胞的數量降低,可能促使ECl09細胞G。/G,期嚮s期跨越的延遲;在此環境中,As2O3也可能通過抑製S期ECl09細胞內F—actin的重組來延遲細胞從G。/G。期進入S期;誘導肥大細胞遷入腹腔的同時加入藥物As20,,其作用主要錶現為短期效應,促進瞭腫瘤細胞內F—aetin含量的降低,G0/G1期細胞數量較高,齣現短暫的延遲Gn/G1期嚮S期跨越,增彊瞭對腫瘤細胞生長的抑製作用.因此,以生物機體為研究環境,可能更真實地呈現化療藥物對腫瘤細胞的治療效果.
목적:세포골가미사시여종류세포생장밀절상관적인소지일,본문이생물궤체복강위면역적미배경,연구화료약물삼양화이신(As2O3)대인식관암세포주미사골가적영향.방법:이용귀필배태(Phalloidin)급전화병정(Propidium Iodide,PI)표기,이류식세포의기술분석소서복강액중식관암ECl09세포주기적각기세포내F—actin적변화.결과:유도비대세포(mastcell,MC)천이입복강적동시,신속승고G0/G1기세포급강저S기세포내적Factin함량,DNA검측결과현시G0/G1기적종류세포수량신속증가(P〈0.05),s기세포함량강저;삼양화이신작용후,식관암세포각기적F-actin함량균강저,우기s기위심.MC화As2O3공동작용후,식관암세포각기적Factin함량균야감소,단G0/G1기세포수량각현저증가.결론:재소서복강미배경중,면역공능개변(면역세포MC적취집)인기G0/G1기세포수량신속승고、S기세포적수량강저,가능촉사ECl09세포G。/G,기향s기과월적연지;재차배경중,As2O3야가능통과억제S기ECl09세포내F—actin적중조래연지세포종G。/G。기진입S기;유도비대세포천입복강적동시가입약물As20,,기작용주요표현위단기효응,촉진료종류세포내F—aetin함량적강저,G0/G1기세포수량교고,출현단잠적연지Gn/G1기향S기과월,증강료대종류세포생장적억제작용.인차,이생물궤체위연구배경,가능경진실지정현화료약물대종류세포적치료효과.
Objective: The microfilament cytoskeleton is one of the factors closely related with the growth of tumor cells. This paper aimed at establishing an immune mieroenvironment in living organisms abdominal, investigating the effects of chemotherapy drug arsenic trioxide (As2O3) on the F-actin cytoskeleton of human esophageal carcinoma EC109 cell line. Method: The cellular F-actin of EC109 cells were labeled with Phalloidin-FITC, DNA in esophageal carcinoma cells were labeled with propidium iodide(PI). The F-actin content in each phase of cancer cell cycle was analyzed by flow cytometry. Results: Mast cell (MC) migrated into the abdominal cavity by induction could increase F-actin content in the G0/G1 phase cells but reduce in S phase. DNA test results showed that MC made the number of tumor cells in G0/G1 phase increase rapidly, while decrease in S phase. As203 reduced F-aetin content of esophageal carcinoma EC109 ceils, especially the F- actin content of S phase cells. With the effects of MC and As2O3, the F-actin content in each phase of EC109 cell cycle was decreased, but a significant increase in the number of cells in G0/G1 phase. Conclusions: In the mouse peritoneal microenvironment, when the immune function changed (this referred to the aggregation of MC), it increased the number of tumor cells in G0/G1 phase rapidly, while decreased in S phase, so it could promote cell cycle G0/G1 phase across into S phase delay. As203 also could delay cells from G0/G1 phase into S phase by inhibition the F-actin reorganization of EC109 cells in S phase. We induced mast cell into the mouse peritoneal, at the same time adding drugs As2O3, and found that its role mainly as a short-term effect, reduced the F-actin content of tumour cell, but a higher number of cells in G0/G1 phase, and might promote a brief delay in the Go/Gt phase to S phase across. Therefore, the research system was in the biological body, this may more realistically show the therapeutic effect of the chemotherapeutic drugs on tumor cells.